Literature DB >> 18978574

Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome.

Cecilia Bech1, Jens Benn Sørensen.   

Abstract

Paraneoplastic syndromes have only been reported in malignant pleural mesothelioma (MPM) in a few cases. In this case, we describe a 57-year-old man with MPM who developed sensory-motor polyneuropathy 18 days after diagnosis. Thorough endocrinological, neurological, and paraclinical examinations gave no explanation of the symptoms, and paraneoplasia was therefore suspected. The patient was treated with immunoglobulin and prednisolone, and this resulted in subjective, objective, and paraclinical improvement of the symptoms. We therefore suggest that polyneuropathy is a possible paraneoplastic syndrome in MPM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978574     DOI: 10.1097/JTO.0b013e3181872764

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  5 in total

Review 1.  Minimal change disease associated with malignant pleural mesothelioma: case report and review of the literature.

Authors:  Halil Yildiz; Stoian Ioana Andreea; Delphine Hoton; Jean Cyr Yombi
Journal:  BMJ Case Rep       Date:  2016-12-19

Review 2.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

3.  A 75 year old male with recurrent unilateral pleural effusion and positive ANA.

Authors:  Tanner Wallen; Nikhil Jagan; Mridula Krishnan; Zachary Depew
Journal:  Respir Med Case Rep       Date:  2019-02-22

4.  Malignant Peritoneal Mesothelioma Presenting with Polymyalgia Rheumatica-like Syndrome.

Authors:  Yuka Ide; Tsunetsugu Yuki; Yasuyuki Taooka; Yusuke Higashi; Yoshiro Tachiyama
Journal:  Intern Med       Date:  2020-06-23       Impact factor: 1.271

Review 5.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.